Advertisement Datatrak to deploy eClinical platform in three Phase III oncology studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Datatrak to deploy eClinical platform in three Phase III oncology studies

Datatrak International has signed an Enterprise Agreement for three new multi-center Phase III oncology studies with an existing client, to deploy its eClinical platform.

The Datatrak eClinical software solution is deployed worldwide through an ASP or Enterprise Transfer offering.

Datatrak chairman and CEO Laurence Birch said that their knowledge of the complex and unique requirements related to oncology trials has been built into Datatrak eClinical; these oncology-specific solutions within the unified platform provide clients with the necessary tools to deliver clinical trials with safety, simplicity and speed.

Datatrak is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry.